POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
UNI - EN REPORT No | 30 | / | 2014 | ||||||||
Date of issue: | 2014-03-17 | ||||||||||
Short name of the issuer | |||||||||||
SOPHARMA AD | |||||||||||
Subject | |||||||||||
Current report 30 re insiders transactions | |||||||||||
Official market - legal basis | |||||||||||
Art. 160 ust 4 Ustawy o obrocie - informacja o transakcjach osуb maj№cych dostкp do informacji poufnych | |||||||||||
Unofficial market - legal basis | |||||||||||
Contents of the report: | |||||||||||
Sopharma AD (the “Company") announces that it was notified by Mr. Ognian Donev, Chairman of the Board of Directors that the company “Donev Investments Holding AD" related to him, executed the following transactions related to shares in the Company: Date and time Operation Number Unit price of the of shares (BGN) settlement 10.03.2014 Buy 112 4.450 11.03.2014 Buy 400 4.405 12.03.2014 Buy 5 4.451 12.03.2014 Sale 33 4.5 13.03.2014 Sale 129 4.5 13.03.2014 Sale 171 4.5 13.03.2014 Sale 329 4.5 14.03.2014 Sale 91 4.55 14.03.2014 Sale 59 4.55 14.03.2014 Sale 100 4.52 The transfer of the above-mentioned shares was executed on the Bulgarian Stock Exchange in Sofia (regulated market) by way of electronic trade. | |||||||||||
Annexes | |||||||||||
File | Description | ||||||||||
Current report 30 re insiders transactions.doc | Current report 30 re insiders transactions |
SOPHARMA AD | |||||||||||||
(fullname of the issuer) | |||||||||||||
SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
(short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
1220 | Sofia | ||||||||||||
(post code) | (city) | ||||||||||||
IlienskoShosse | 16 | ||||||||||||
(street) | (number) | ||||||||||||
+359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
(phone number) | (fax) | ||||||||||||
(e-mail) | (web site) | ||||||||||||
nd | |||||||||||||
(NIP) | (REGON) |
SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
Date | Name | Position / Function | Signature | ||
2014-03-17 | Ognian Donev | Executive director |